We integrated existing studies exploring the association between MCM3AP-AS1 and OS, RFS, and CFS of cancer patients and performed a meta-analysis to assess the potential of MCM3AP-AS1 as a therapeutic target and prognostic marker for cancer. This evidence concerns the gene MCM3AP and cancer.